Back to Results
Determination of incidence and risk factors for colon problems in patients with CF
||A Long Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis (CF) Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
||Scott Schroeder, MD
This is a prospective observational study to determine the incidence of fibrosing colonpathy in patients with CF.
- Patients must have diagnosis of Cystic Fibrosis and take pancreatic enzyme supplements
Observational study. There are no tests and no x-rays.